Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans

By Yamada I.   Fujino H.   Shimada S.   Kojima J.  

Xenobiotica, Vol. 33, Iss. 7, 2003-07 ,pp. : 789-803

Informa Healthcare

Access to resources Recommend Favorite

Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors

By Fujino H.   Saito T.   Tsunenari Y.   Kojima J.   Sakaeda T.  

Xenobiotica, Vol. 34, Iss. 11-12, 2004-11 ,pp. : 961-971

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effect of anthocyanidins on hepatic glutathione S-transferase, UDP-glucuronosyltransferase and carbonyl reductase activities in rat and human

By Szotáková Barbora   Bártíková Hana   Hlaváčová Jitka   Boušová Iva   Skálová Lenka  

Xenobiotica, Vol. 43, Iss. 8, 2013-08 ,pp. : 679-685

Informa Healthcare

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors Reduce Adhesion of Human Monocytes to Endothelial Cells

By Teupser D.   Bruegel M.   Stein O.   Stein Y.   Thiery J.  

Biochemical and Biophysical Research Communications, Vol. 289, Iss. 4, 2001-12 ,pp. : 838-844

Elsevier

Access to resources Recommend Favorite

Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues

By Court Michael H.   Zhang Xiuling   Ding Xinxin   Yee Karen K.   Hesse Leah M.   Finel Moshe  

Xenobiotica, Vol. 42, Iss. 3, 2012-03 ,pp. : 266-277

Informa Healthcare

Access to resources Recommend Favorite